A 34-year-old man is being evaluated in an emergency clinic for dizziness and headache after a stressful event at work. He also reports that his face often becomes swollen and he occasionally has difficulty breathing during these spells. Family history is significant for his father who died of a stroke and his mother who often suffers from similar facial swelling. The patient’s blood pressure is 170/80 mm Hg. On physical examination, the patient appears well. Which of the following medications is most likely contraindicated in this patient?

The patient has no contraindications.

A 56-year-old Caucasian male presents to the clinic to establish care. He has never seen a physician and denies any known medical problems. Physical examination is notable for central obesity, but the patient has regular heart and lung sounds. He has a blood pressure of 157/95 mm Hg and heart rate of 92/min. He follows up 2 weeks later, and his blood pressure continues to be elevated. At this time, you diagnose him with essential hypertension and decide to initiate antihypertensive therapy. Per the Joint National Committee 8 guidelines for treatment of high blood pressure, of the following combinations of drugs, which can be considered for first-line treatment of high blood pressure in the Caucasian population?

ACE inhibitor, ARB, CCB, or thiazide

ACE inhibitor, angiotensin receptor blocker (ARB), beta-blocker (BB), or thiazide

ACE inhibitor, ARB, CCB, or loop diuretic

ACE inhibitor, ARB, alpha-blocker, or loop diuretic

ACE inhibitor, ARB, alpha-blocker, or direct vasodilator

A 56-year-old man presents to the family medicine office since he has been having difficulty keeping his blood pressure under control for the past month. He has a significant medical history of hypertension, coronary artery disease, and diabetes mellitus. He has a prescription for losartan, atenolol, and metformin. The blood pressure is 178/100 mm Hg, the heart rate is 92/min, and the respiratory rate is 16/min. The physical examination is positive for a grade II holosystolic murmur at the left sternal border. He also has diminished sensation in his toes. Which of the following statements is the most effective means of communication between the doctor and the patient?

“What is causing your blood pressure to be elevated?”

“Have you been taking your medications as prescribed?”

“Would you like us to consider trying a different medication for your blood pressure?”

“You are taking your medications as prescribed, aren’t you?”

“Why are you not taking your medication?”

A 27-year-old G1P0 woman at 25 weeks estimated gestational age presents with a blood pressure of 188/99 mm Hg during a routine prenatal visit. She has no symptoms, except for a mild headache. The patient's heart rate is 78/min. An injectable antihypertensive along with a beta-blocker is administered, and her blood pressure returns to normal within a couple of hours. She is sent home with advice to continue the beta-blocker. The patient returns after a couple of weeks with joint pain in both of her knees and fatigue. A blood test for anti-histone antibodies is positive. Which of the following is the mechanism of action of the intravenous antihypertensive medication most likely used in this patient?

Interference with action of inositol trisphosphate (IP3) on intracellular calcium release

Release endogenous nitric oxide

Inhibition of phosphodiesterase enzyme

A 42-year-old man presents to his primary care physician for preventative care. He does not have any current complaint. His father died of diabetic nephropathy. Vital signs include a temperature of 36.7°C (98.06°F), blood pressure of 150/95 mm Hg, and pulse of 90/min. His fasting blood glucose is 159 mg/dL (on 2 occasions) and HbA1c is 8.1%. The patient is started on metformin and lifestyle modifications. 3 months later, he comes for a follow-up visit. His serum blood glucose is 370 mg/dL and HbA1C is 11%. The patient currently complains of weight loss and excessive urination. Which of the following is the optimal therapy for this patient?

A thiazolidinedione added to metformin

Basal insulin added to metformin

A sulfonylurea added to metformin

A sodium-glucose cotransporter 2 inhibitor added to metformin

Combination antihypertensive therapy for USMLE Step 2 CK: High-Yield Pharmacology Lessons

Combination Rationale - Why Double Up?

Synergistic BP Lowering: Using lower doses of two drugs from different classes often yields greater BP reduction with fewer dose-related side effects than maximizing a single agent.
Counteract Reflex Mechanisms: One agent can blunt compensatory physiological responses triggered by another (e.g., a beta-blocker preventing reflex tachycardia from a vasodilator).
Improved Adherence: Single-pill combinations simplify regimens, boosting patient compliance.
When to Initiate Combination Therapy (ACC/AHA):
- Stage 2 Hypertension: Start with two first-line agents from different classes when BP is ≥140/90 mmHg.
  
  ⭐ For patients with BP >20/10 mmHg above their goal, initiating therapy with two agents is a Class I recommendation.

Preferred Pairings - The Dynamic Duos

Combining drugs with complementary mechanisms enhances efficacy and may reduce adverse effects. The most effective pairings are centered around RAAS inhibitors.

ACEi/ARB + Thiazide Diuretic: A powerful pairing. Thiazides lower blood volume but can cause reflex RAAS activation. The ACEi/ARB directly blocks this compensatory mechanism, resulting in a strong synergistic BP-lowering effect.
ACEi/ARB + Dihydropyridine CCB: An excellent combination. The ACEi/ARB mitigates common CCB side effects like peripheral edema (by balancing arteriolar dilation with venodilation) and reflex tachycardia.

⭐ Combining an ACE inhibitor with an ARB or a direct renin inhibitor (Aliskiren) is not recommended. This dual RAAS blockade offers minimal added BP benefit while significantly ↑ the risk of hyperkalemia, hypotension, and acute kidney injury.

Hazardous Handshakes - The Forbidden Dance

Certain antihypertensive combinations offer no synergy and may instead cause significant harm. Avoiding these pairings is crucial for patient safety.

Combination	Reason to Avoid
ACE Inhibitor + ARB	Redundant RAAS blockade. ↑ risk of hyperkalemia, hypotension, and acute kidney injury without added benefit.
ACEi/ARB + K⁺-Sparing Diuretic	Additive effect on potassium retention, leading to a high risk of severe hyperkalemia.
Beta-Blocker + Non-DHP CCB	Additive negative chronotropic and inotropic effects. ↑ risk of severe bradycardia, AV block, and heart failure.

Compelling Indications - Patient-Specific Plays

Diabetes & Chronic Kidney Disease (CKD): ACE inhibitor (ACEi) or ARB is first-line. Add a Thiazide diuretic or Calcium Channel Blocker (CCB) if needed. This is critical for renoprotection, especially with albuminuria (>300 mg/day).
Post-Myocardial Infarction (Post-MI): Combine a Beta-blocker with an ACEi/ARB. This pairing is proven to reduce mortality and prevent adverse cardiac remodeling.
Secondary Stroke Prevention: A Thiazide diuretic plus an ACEi is the evidence-based combination to significantly lower the risk of a recurrent stroke.

⭐ In African American patients without heart failure or CKD, initial therapy with a Thiazide or CCB is generally more effective for lowering blood pressure than an ACEi or ARB.

Initiate combination therapy for Stage 2 HTN (BP >140/90 mmHg) or if pressure is >20/10 mmHg above goal.

Preferred pairings combine a RAAS inhibitor (ACEi/ARB) with a dihydropyridine CCB or a thiazide diuretic.

ACEi/ARBs can mitigate thiazide-induced hypokalemia and reduce CCB-associated peripheral edema.

NEVER combine an ACE inhibitor with an ARB due to severe risks of hyperkalemia and renal failure.

Avoid pairing beta-blockers with non-dihydropyridine CCBs to prevent severe bradycardia.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play